_vitiligo-predictions-of-the-future.jpg "Vitiligo (Predictions Of The Future) from bone resorption inhibitor drugs Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 4:51
✓ Published: 08-Apr-2024
✓ Published: 08-Apr-2024
Description:
Vitiligo treatments are advancing in leaps and bounds, and as more understanding is developed on the processes involved in the pathophysiology of this condition, we can expect to see even more progress. The JAK/STAT inhibitors have created new therapeutic opportunities that have produced remarkable results. The success of the first JAK/STAT inhibitor has opened the gates for a flood of potential drugs to treat vitiligo. After ruxolitinib, other medications such as povorcitinib and baricitinib have joined the list of potential JAK/STAT inhibitors for the treatment of vitiligo. Recognition of the central role the JAK/STAT pathway plays in the pathophysiology of this condition has created other possibilities, including medications that will block other players in the pathway like MMP-9 or other cytokines. With the current investigations ongoing, we can expect the introduction of several novel treatments in the near future that promise to finally put an end to the suffering caused by this condition.
Vitiligo treatments are advancing in leaps and bounds, and as more understanding is developed on the processes involved in the pathophysiology of this condition, we can expect to see even more progress. The JAK/STAT inhibitors have created new therapeutic opportunities that have produced remarkable results. The success of the first JAK/STAT inhibitor has opened the gates for a flood of potential drugs to treat vitiligo. After ruxolitinib, other medications such as povorcitinib and baricitinib have joined the list of potential JAK/STAT inhibitors for the treatment of vitiligo. Recognition of the central role the JAK/STAT pathway plays in the pathophysiology of this condition has created other possibilities, including medications that will block other players in the pathway like MMP-9 or other cytokines. With the current investigations ongoing, we can expect the introduction of several novel treatments in the near future that promise to finally put an end to the suffering caused by this condition.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_pharmacology-drugs-for-osteoporosis-made-easy.webp "Speed Pharmacology")
_osteoporosis-medications-pharmacology-musculoskeletal-124-leveluprn.webp "Level Up RN")
⏲ 5 minutes 58 seconds 👁 20.5K
_worst-drug-for-osteoporosis-bisphosphonate-drugs-fear-confusion-and-facts.webp "The Dr Doug Show | Bones, Hormones and HealthSpan")
⏲ 27 minutes 14 seconds 👁 134.3K
_bisphosphonates-101-124-pharmacology-help-for-nursing-students.webp "NurseInTheMaking")
_pharmacology-drugs-for-osteoporosis-made-easy.jpg)
_osteoporosis-medications-pharmacology-musculoskeletal-124-leveluprn.jpg)
_worst-drug-for-osteoporosis-bisphosphonate-drugs-fear-confusion-and-facts.jpg)
_bisphosphonates-101-124-pharmacology-help-for-nursing-students.jpg)
![[+]](/images/menu.gif){kind=small}